STERN ADAM K

Average Profitability
55.57%
Insider Buys Quantity
29
Insider Buys Sum
$539,529.96
Insider Sells Quantity
0
Insider Sells Sum
$0

Insider Activity of STERN ADAM K

The largest purchase of all time was on 2019-05-16 and amounted to 150000 shares of Matinas BioPharma Holdings, Inc. for $142,500.

Biography of STERN ADAM K

No biography is available at this moment.

2021-03-01PurchaseDarioHealth Corp.
DRIO
director
619
$0$0-42.88%
2021-02-03PurchaseDarioHealth Corp.
DRIO
director
619
$0$0-34.08%
2021-01-19PurchaseDarioHealth Corp.
DRIO
director
43,850
$0$0-15.98%
2021-01-04PurchaseDarioHealth Corp.
DRIO
director
619
$0$0+8.96%
2020-12-02PurchaseDarioHealth Corp.
DRIO
director
619
$0$0+37.78%
2020-11-02PurchaseDarioHealth Corp.
DRIO
director
619
$0$0+52.49%
2020-10-02PurchaseDarioHealth Corp.
DRIO
director
619
$0$0-2.12%
2020-09-03PurchaseDarioHealth Corp.
DRIO
director
639
0.0036%
$6.66$4,256+5.28%
2020-08-21PurchaseMatinas BioPharma Holdings, Inc.
MTNB
director
20,000
0.01%
$0.83$16,600+3.36%
2020-08-03PurchaseDarioHealth Corp.
DRIO
director
639
0.0041%
$6.66$4,256+22.62%
2020-07-20PurchaseDarioHealth Corp.
DRIO
director
1,450
$0$0+151.81%
2020-07-03PurchaseDarioHealth Corp.
DRIO
director
639
0.0092%
$6.66$4,256
2020-06-08PurchaseDarioHealth Corp.
DRIO
director
2,500
0.0607%
$5.89$14,730+176.49%
2020-06-03PurchaseDarioHealth Corp.
DRIO
director
639
0.0176%
$6.66$4,256+173.29%
2020-05-07PurchaseDarioHealth Corp.
DRIO
director
639
0.0133%
$6.66$4,256+97.88%
2020-04-20PurchaseDarioHealth Corp.
DRIO
director
639
0.0165%
$6.66$4,256+121.12%
2020-04-03PurchaseDarioHealth Corp.
DRIO
director
493
$0$0+157.42%
2020-03-20PurchaseDarioHealth Corp.
DRIO
director
14,500
0.4146%
$3.80$55,100+200%
2020-03-17PurchaseMatinas BioPharma Holdings, Inc.
MTNB
director
10,000
0.0051%
$0.65$6,500+25.71%
2019-08-19PurchaseMatinas BioPharma Holdings, Inc.
MTNB
director
10,400
0.0068%
$0.70$7,268+20.39%
Prismo does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. Prismo does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.